triamcinolone acetonide has been researched along with Disease Exacerbation in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 24 (66.67) | 29.6817 |
| 2010's | 12 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brennan, J; Hall, AJ; Hodgson, L; Lim, LL; Ma, SP; Rogers, SL; Stawell, RJ | 1 |
| Bolz, M; Huf, W; Kiss, CG; Munk, MR; Roberts, P; Rückert, R; Simader, C; Sulzbacher, F | 1 |
| Abu-Mugheisib, M; Benecke, R; Hoffmann, F; Kamin, F; Koehler, W; Petzold, A; Rommer, PS; Tumani, H; Winkelmann, A; Zettl, UK | 1 |
| Beselga, D; Campos, A; Campos, J; Mendes, S; Neves, A; Sousa, P | 1 |
| Park, YG; Roh, YJ | 1 |
| Jia, Y; Miao, H; Wang, L; Yang, Y; Zhang, XY; Zhou, YS | 1 |
| Chang, MC; Huang, TF; Huang, YC; Wang, JP; Yin, CY; Yu, HM | 1 |
| Esfahani, MR; Faghihi, H; Farahvash, MS; Rajabi, MT; Taheri, A | 1 |
| Spaide, RF | 1 |
| Durmaz, S; Kandemir, N; Kocabora, MS | 1 |
| Makay, B; Unsal, E | 1 |
| Byun, YS; Park, YH | 1 |
| Chen, SH; Shah, AS | 1 |
| Beck, RW; Bressler, NM; Edwards, AR; Flaxel, CJ; Glassman, AR; Ip, MS; Kollman, C; Kuppermann, BD; Stone, TW | 1 |
| Kiavash, V; Peyman, GA; Rabbanikhah, Z; Ramezani, A; Soheilian, M; Yaseri, M | 1 |
| Aaberg, TM; Bergstrom, C; Payne, JF; Srivastava, SK; Yan, J | 1 |
| Beck, RW; Bressler, NM; Chew, EY; Ferris, FL; Fish, GE; Glassman, AR; Kinyoun, JL | 1 |
| Abu-Mugheisib, M; Benecke, R; Zettl, UK | 1 |
| Asano, Y; Hida, T; Kawahara, S; Kojima, E; Morimura, Y; Okada, AA; Wakabayashi, T | 1 |
| Akkoyun, I; Degenring, RF; Friedemann, T; Jonas, JB; Kreissig, I | 1 |
| Lang, GE | 1 |
| Erkiliç, K; Ozkiriş, A | 1 |
| Akar, Y; Barile, GR; Cekiç, O; Chang, S; Schiff, WM; Tseng, JJ | 1 |
| Brune, N; Hellwig, K; Hoffmann, V; Islamova, S; Kuhn, W; Lukas, C; Müller, T; Pöhlau, D; Przuntek, H; Schimrigk, S | 1 |
| Thompson, JT | 1 |
| Leelapatranura, K; Phonjan, T; Prabhasawat, P; Tesavibul, N | 1 |
| Bouter, LM; Croft, P; Hay, EM; Lewis, M; Smidt, N; VAN DER Windt, DA | 1 |
| Engin, G; Gulkilik, G; Kucuksahin, H; Selim Kocabora, M; Taskapili, M; Yilmazli, C | 1 |
| Chu, YK; Chung, EJ; Koh, HJ; Kwon, OW; Lee, JH | 1 |
| Tugal-Tutkun, I; Tuncer, S; Urgancioglu, M; Yilmaz, S | 1 |
| Brasil, OM; Galor, A; Kaiser, PK; Lowder, CY; Margolis, R; Perez, VL; Sears, JE; Smith, SD | 1 |
| Fukushima, M; Inatani, M; Inomata, Y; Iwao, K; Kawaji, T; Sagara, N; Takano, A; Tanihara, H | 1 |
| Bao, S; Gillies, MC; Lai, D; Rapkins, RW; Zhang, X | 1 |
| Endo, H; Hallmon, WW; Kato, T; Kono, Y; Kuyama, K; Nakadai, M; Rees, TD; Yamamoto, H | 1 |
| Backhouse, O; Bhan, KJ; Bishop, F | 1 |
| Kim, SY; Lee, YC; Park, YH; Yang, J | 1 |
4 review(s) available for triamcinolone acetonide and Disease Exacerbation
| Article | Year |
|---|---|
New Diagnostic and Therapeutic Approaches for Preventing the Progression of Diabetic Retinopathy.
Topics: Diabetic Retinopathy; Disease Progression; Early Diagnosis; Fluorescein Angiography; Humans; Low-Level Light Therapy; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2016 |
Cataract surgery and diabetes.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Disease Progression; Glucocorticoids; Humans; Laser Coagulation; Macular Edema; Phacoemulsification; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2010 |
Management of spasticity in progressive multiple sclerosis: efficacy of repeated intrathecal triamcinolone acetonide administration.
Topics: Anti-Inflammatory Agents; Disability Evaluation; Disease Progression; Drug Administration Schedule; Humans; Injections, Spinal; Multiple Sclerosis, Chronic Progressive; Muscle Spasticity; Triamcinolone Acetonide | 2012 |
[Pharmacological treatment of diabetic retinopathy].
Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Humans; Injections; Macular Edema; Multicenter Studies as Topic; Octreotide; Prospective Studies; Protein Kinase C; Somatostatin; Triamcinolone Acetonide; Vitreous Body | 2004 |
10 trial(s) available for triamcinolone acetonide and Disease Exacerbation
| Article | Year |
|---|---|
Long-term follow-up of Dupuytren disease after injection of triamcinolone acetonide in Chinese patients in Taiwan.
Topics: Aged; Aged, 80 and over; Asian People; Disease Progression; Dupuytren Contracture; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections, Intralesional; Male; Middle Aged; Taiwan; Triamcinolone Acetonide; Ultrasonography | 2017 |
Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
Topics: Adult; Aged; Cataract; Diabetes Complications; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Postoperative Care; Reoperation; Secondary Prevention; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body; Vitreous Hemorrhage; Young Adult | 2008 |
Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation.
Topics: Diabetic Retinopathy; Disease Progression; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Probability; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Bevacizumab vs. triamcinolone.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Cataract; Disease Progression; Female; Glucocorticoids; Humans; Macula Lutea; Macular Edema; Male; Pilot Projects; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vascular Endothelial Growth Factor A; Visual Acuity | 2010 |
Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema.
Topics: Aged; Cataract; Cataract Extraction; Combined Modality Therapy; Diabetic Retinopathy; Disease Progression; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Coagulation; Lens, Crystalline; Macular Edema; Middle Aged; Ocular Hypertension; Orbit; Risk Factors; Tenon Capsule; Triamcinolone Acetonide | 2011 |
Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Disease Progression; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections, Intralesional; Intraocular Pressure; Macular Degeneration; Male; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Repeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patients.
Topics: Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents; Disability Evaluation; Disease Progression; Drug Administration Schedule; Female; Humans; Injections, Spinal; Male; Middle Aged; Multiple Sclerosis; Phosphopyruvate Hydratase; S100 Proteins; Severity of Illness Index; Treatment Outcome; Triamcinolone Acetonide; Walking | 2006 |
Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Conjunctiva; Disease Progression; Female; Fluorouracil; Follow-Up Studies; Glucocorticoids; Humans; Injections; Injections, Intralesional; Male; Middle Aged; Prospective Studies; Pterygium; Recurrence; Survival Analysis; Treatment Outcome; Triamcinolone Acetonide | 2006 |
[Treatment of diabetic macular edema with intravitreal triamcinolone acetonide injection: functional and anatomical outcomes].
Topics: Adult; Aged; Anti-Inflammatory Agents; Blood-Retinal Barrier; Cataract; Diabetic Retinopathy; Disease Progression; Endophthalmitis; Female; Glaucoma; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Objective evaluation of cataract progression associated with a high dose intravitreal triamcinolone injection.
Topics: Aged; Cataract; Diabetic Retinopathy; Disease Progression; Drug Administration Schedule; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
22 other study(ies) available for triamcinolone acetonide and Disease Exacerbation
| Article | Year |
|---|---|
Sarcoidosis-related Uveitis: Clinical Presentation, Disease Course, and Rates of Systemic Disease Progression After Uveitis Diagnosis.
Topics: Adult; Biopsy; Diagnosis, Differential; Disease Progression; Eye Diseases; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphadenopathy; Male; Middle Aged; Prednisolone; Retrospective Studies; Risk Factors; Sarcoidosis; Time Factors; Tomography, X-Ray Computed; Triamcinolone Acetonide; Uveitis; Visual Acuity | 2019 |
Morphologic and functional evaluations during development, resolution, and relapse of uveitis-associated cystoid macular edema.
Topics: Disease Progression; Epiretinal Membrane; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Retinal Detachment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis, Anterior; Visual Acuity | 2013 |
Effects of repeated intrathecal triamcinolone-acetonide application on cerebrospinal fluid biomarkers of axonal damage and glial activity in multiple sclerosis patients.
Topics: Adult; Anti-Inflammatory Agents; Axons; Biomarkers; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Injections, Spinal; Male; Middle Aged; Multiple Sclerosis; Neurofilament Proteins; Neuroglia; Prognosis; Prospective Studies; S100 Calcium Binding Protein beta Subunit; tau Proteins; Triamcinolone Acetonide | 2014 |
Deferred intravitreal triamcinolone in diabetic eyes after phacoemulsification.
Topics: Aged; Aged, 80 and over; Diabetic Retinopathy; Disease Progression; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Phacoemulsification; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide | 2014 |
[Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Arthritis; Cyclophosphamide; Disease Progression; Female; Hematologic Diseases; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Pain; Prognosis; Raynaud Disease; Recurrence; Scleritis; Serositis; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vision Disorders | 2016 |
Intravitreal triamcinolone.
Topics: Cataract; Disease Progression; Glucocorticoids; Humans; Injections; Intraocular Pressure; Lens Capsule, Crystalline; Macular Edema; Risk Factors; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2008 |
Exacerbation of central serous chorioretinopathy following intravitreal triamcinolone injection.
Topics: Choroid Diseases; Disease Progression; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Recurrence; Retinal Detachment; Retinal Diseases; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2008 |
Intraarticular triamcinolone in juvenile idiopathic arthritis.
Topics: Age Factors; Anti-Inflammatory Agents; Arthritis, Juvenile; Child; Disease Progression; Female; Humans; Immunosuppressive Agents; Injections, Intra-Articular; Male; Remission Induction; Treatment Outcome; Triamcinolone Acetonide | 2008 |
Complications and safety profile of posterior subtenon injection of triamcinolone acetonide.
Topics: Cataract; Disease Progression; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Triamcinolone Acetonide | 2009 |
Residual triamcinolone acetonide sequestered in the fovea after macular hole repair.
Topics: Coloring Agents; Disease Progression; Epiretinal Membrane; Eyeglasses; Female; Follow-Up Studies; Fovea Centralis; Fundus Oculi; Gases; Glucocorticoids; Humans; Indocyanine Green; Injections, Intraocular; Intraocular Pressure; Male; Middle Aged; Postoperative Period; Retinal Perforations; Staining and Labeling; Tissue Distribution; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2011 |
Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cataract; Disease Progression; Female; Glucocorticoids; Humans; Infusions, Intralesional; Intraocular Pressure; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis, Posterior; Visual Acuity | 2003 |
Complications of intravitreal injection of triamcinolone acetonide.
Topics: Cataract; Cataract Extraction; Disease Progression; Endophthalmitis; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 2005 |
Cataract progression after intravitreal triamcinolone injection.
Topics: Aged; Aged, 80 and over; Cataract; Choroidal Neovascularization; Disease Progression; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Lens, Crystalline; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Cataract formation and other complications of intravitreal triamcinolone for macular edema.
Topics: Aged; Cataract; Disease Progression; Glucocorticoids; Humans; Injections; Intraocular Pressure; Lens, Crystalline; Macular Edema; Retrospective Studies; Time Factors; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Lateral epicondylitis in general practice: course and prognostic indicators of outcome.
Topics: Adult; Anti-Inflammatory Agents; Decision Making; Disease Progression; Female; Follow-Up Studies; Humans; Injections; Linear Models; Male; Pain; Pain Management; Physical Therapy Modalities; Prospective Studies; Tennis Elbow; Time Factors; Treatment Outcome; Triamcinolone Acetonide | 2006 |
Results of intravitreal triamcinolone acetonide (IVTA) injection for the treatment of panuveitis attacks in patients with Behçet disease.
Topics: Acute Disease; Adolescent; Adult; Behcet Syndrome; Cataract; Disease Progression; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Panuveitis; Recurrence; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2007 |
Adverse events after intravitreal triamcinolone in patients with and without uveitis.
Topics: Aged; Cataract; Disease Progression; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Lens Capsule, Crystalline; Macular Edema; Male; Middle Aged; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2007 |
Trans-Tenon's retrobulbar triamcinolone acetonide injection for macular oedema related to branch retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Cataract; Disease Progression; Drug Evaluation; Female; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2008 |
Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas.
Topics: Animals; Blood-Retinal Barrier; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Progression; Glucocorticoids; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2008 |
Disease progression from mucosal to mucocutaneous involvement in a patient with desquamative gingivitis associated with pemphigus vulgaris.
Topics: Adult; Desmoglein 1; Desmoglein 3; Disease Progression; Female; Gingival Diseases; Glucocorticoids; Humans; Pemphigus; Skin Diseases; Triamcinolone Acetonide | 2008 |
Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis.
Topics: Disease Progression; Glucocorticoids; Humans; Injections; Male; Middle Aged; Toxoplasmosis, Ocular; Triamcinolone Acetonide | 2008 |
Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery.
Topics: Aged; Aged, 80 and over; Connective Tissue; Diabetic Retinopathy; Disease Progression; Female; Glucocorticoids; Humans; Incidence; Injections; Intraoperative Care; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Phacoemulsification; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2008 |